TY - JOUR
T1 - Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells
AU - Zimmerman, Aukje W
AU - Joosten, Ben
AU - Torensma, Ruurd
AU - Parnes, Jane R
AU - van Leeuwen, Frank N
AU - Figdor, Carl G
PY - 2006/4/15
Y1 - 2006/4/15
N2 - Interactions between T cells and antigen-presenting cells (APCs) are the first step in the induction of an adaptive immune response. Here, we show that CD6 and its ligand activated leukocyte cell adhesion molecule (ALCAM) are actively recruited to the antigen-induced dendritic cell (DC)-T-cell contact zone. Moreover, ALCAM-blocking antibodies interfere with DC-T-cell conjugate formation, demonstrating that CD6-ALCAM binding is essential for stable T-cell-APC contact. We now demonstrate that besides their role in establishing initial contacts, CD6-ALCAM interactions are also required during the proliferative phase of the T-cell response; the presence of CD6-blocking antibodies or recombinant ALCAM-Fc proteins results in a strong and sustained inhibition of T-cell proliferation. Furthermore, simultaneous crosslinking of CD6 and CD3 induces enhanced proliferation and transcriptional activity to a similar level as observed after CD3 and CD28 co-crosslinking, demonstrating that CD6 is an important costimulatory molecule. The stability of ALCAM-CD6 binding, which contrasts with transient homotypic ALCAM-ALCAM interactions, further supports the long-lasting effects observed on T-cell proliferation. Taken together, we demonstrate that CD6 and ALCAM form a key adhesive receptor-ligand pair that is not only involved in early DC-T-cell binding but also in sustaining DC-induced T-cell proliferation long after the initial contact has been established.
AB - Interactions between T cells and antigen-presenting cells (APCs) are the first step in the induction of an adaptive immune response. Here, we show that CD6 and its ligand activated leukocyte cell adhesion molecule (ALCAM) are actively recruited to the antigen-induced dendritic cell (DC)-T-cell contact zone. Moreover, ALCAM-blocking antibodies interfere with DC-T-cell conjugate formation, demonstrating that CD6-ALCAM binding is essential for stable T-cell-APC contact. We now demonstrate that besides their role in establishing initial contacts, CD6-ALCAM interactions are also required during the proliferative phase of the T-cell response; the presence of CD6-blocking antibodies or recombinant ALCAM-Fc proteins results in a strong and sustained inhibition of T-cell proliferation. Furthermore, simultaneous crosslinking of CD6 and CD3 induces enhanced proliferation and transcriptional activity to a similar level as observed after CD3 and CD28 co-crosslinking, demonstrating that CD6 is an important costimulatory molecule. The stability of ALCAM-CD6 binding, which contrasts with transient homotypic ALCAM-ALCAM interactions, further supports the long-lasting effects observed on T-cell proliferation. Taken together, we demonstrate that CD6 and ALCAM form a key adhesive receptor-ligand pair that is not only involved in early DC-T-cell binding but also in sustaining DC-induced T-cell proliferation long after the initial contact has been established.
KW - Antibodies, Monoclonal/genetics
KW - Antigen Presentation/drug effects
KW - Antigens, CD/genetics
KW - Antigens, Differentiation, T-Lymphocyte/immunology
KW - CD28 Antigens/immunology
KW - CD3 Complex/immunology
KW - Cell Adhesion Molecules, Neuronal/genetics
KW - Cell Communication/drug effects
KW - Cell Differentiation/drug effects
KW - Cells, Cultured
KW - Dendritic Cells/cytology
KW - Fetal Proteins/genetics
KW - Humans
KW - Recombinant Fusion Proteins/genetics
KW - T-Lymphocytes/cytology
KW - Time Factors
U2 - 10.1182/blood-2005-09-3881
DO - 10.1182/blood-2005-09-3881
M3 - Article
C2 - 16352806
SN - 0006-4971
VL - 107
SP - 3212
EP - 3220
JO - Blood
JF - Blood
IS - 8
ER -